About Parkinson’s disease. Parkinson’s disease affects both men and women in almost equal numbers with no obvious social, ethnic, economic or geographic links in the United States, it is estimated that 60,000 new cases are diagnosed each. Year, joining the 1.5 million Americans who currently developing Parkinson’s disease While the condition usually after the age of 65, 15 percent of those diagnosed under 50 years is estimated to be approximately 1,000 patients in Europe.
The company has additional pre – clinical programs on targets such as mGluR and a proprietary drug discovery platform targeting GPCRs .. About Faust PharmaceuticalsFaust Pharmaceuticals is a specialist in clinical products in the discovery and development of drugs for diseases of the nervous system, the company lead compound is a small molecule glutamate inhibitor in phase II for the treatment of Parkinson’s disease and ALS. A second compound is a fetal gene activating utrophin inducer in preparation for phase I / II for Duchenne muscular dystrophy.The researchers identified Linked mortality rates Chronic Kidney Disease Chronic Kidney DiseaseIn patients with moderate to severe chronic renal disease , treatment with an activated vitamin D.